Nausea and vomiting

Clinical criteria:

  • The condition must be associated with cytotoxic chemotherapy being used to treat malignancy which occurs within 48 hours of chemotherapy administration.

Note

No increase in the maximum quantity or number of units may be authorised.

Note

This drug is not PBS-subsidised for administration with oral 5-HT3 antagonists.